Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Hanna Luukinen"'
Autor:
Milka Marjut Hammarén, Hanna Luukinen, Alina Sillanpää, Kim Remans, Karine Lapouge, Tânia Custódio, Christian Löw, Henna Myllymäki, Toni Montonen, Markus Seeger, Joseph Robertson, Tuula A. Nyman, Kirsi Savijoki, Mataleena Parikka
Publikováno v:
mSystems, Vol 8, Iss 3 (2023)
ABSTRACT The antibiotic-tolerant biofilms present in tuberculous granulomas add an additional layer of complexity when treating mycobacterial infections, including tuberculosis (TB). For a more efficient treatment of TB, the biofilm forms of mycobact
Externí odkaz:
https://doaj.org/article/501c037b6eb44b27a27fb1103b3d93a8
Autor:
Kirsi Savijoki, Henna Myllymäki, Hanna Luukinen, Lauri Paulamäki, Leena-Maija Vanha-aho, Aleksandra Svorjova, Ilkka Miettinen, Adyary Fallarero, Teemu O. Ihalainen, Jari Yli-Kauhaluoma, Tuula A. Nyman, Mataleena Parikka
Publikováno v:
mSystems, Vol 6, Iss 3 (2021)
Mycobacteria are naturally resilient, and mycobacterial infections are notoriously difficult to treat with antibiotics, with biofilm formation being the main factor complicating the successful treatment of tuberculosis (TB). The present study shows t
Externí odkaz:
https://doaj.org/article/16725e605e6c4de2aaa60e074a5c7d62
Publikováno v:
Disease Models & Mechanisms, Vol 11, Iss 3 (2018)
Roughly one third of the human population carries a latent Mycobacterium tuberculosis infection, with a 5-10% lifetime risk of reactivation to active tuberculosis and further spreading the disease. The mechanisms leading to the reactivation of a late
Externí odkaz:
https://doaj.org/article/0674eb9a865949698e60407d6d1edb3d
Autor:
Hanna Luukinen, Milka Marjut Hammarén, Leena-Maija Vanha-aho, Aleksandra Svorjova, Laura Kantanen, Sampsa Järvinen, Bruno Vincent Luukinen, Eric Dufour, Mika Rämet, Vesa Pekka Hytönen, Mataleena Parikka
Publikováno v:
Disease Models & Mechanisms, Vol 11, Iss 1 (2018)
Mycobacterium tuberculosis remains one of the most problematic infectious agents, owing to its highly developed mechanisms to evade host immune responses combined with the increasing emergence of antibiotic resistance. Host-directed therapies aiming
Externí odkaz:
https://doaj.org/article/91d8d6339ef84500826fc85208d28aa7
Autor:
Ilkka Miettinen, Henna Myllymäki, Lauri Paulamäki, Leena-Maija Vanha-aho, Mataleena Parikka, Adyary Fallarero, Tuula A. Nyman, Teemu O. Ihalainen, Hanna Luukinen, Kirsi Savijoki, Aleksandra Svorjova, Jari Yli-Kauhaluoma
Publikováno v:
mSystems, Vol 6, Iss 3 (2021)
mSystems
mSystems, 6 (3)
mSystems
mSystems, 6 (3)
The complex cell wall and biofilm matrix (ECM) act as key barriers to antibiotics in mycobacteria. Here, the ECM and envelope proteins of Mycobacterium marinum ATCC 927, a nontuberculous mycobacterial model, were monitored over 3 months by label-free
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00157a080d1c99dfbea016534898f907
https://trepo.tuni.fi/handle/10024/133488
https://trepo.tuni.fi/handle/10024/133488
Publikováno v:
J Vis Exp
Mycobacterium tuberculosis is currently the deadliest human pathogen causing 1.7 million deaths and 10.4 million infections every year. Exposure to this bacterium causes a wide disease spectrum in humans ranging from a sterilized infection to an acti
Autor:
Hanna, Luukinen, Milka Marjut, Hammarén, Leena-Maija, Vanha-Aho, Aleksandra, Svorjova, Laura, Kantanen, Sampsa, Järvinen, Bruno Vincent, Luukinen, Eric, Dufour, Mika, Rämet, Vesa Pekka, Hytönen, Mataleena, Parikka
Publikováno v:
Disease Models & Mechanisms
Mycobacterium tuberculosis remains one of the most problematic infectious agents, owing to its highly developed mechanisms to evade host immune responses combined with the increasing emergence of antibiotic resistance. Host-directed therapies aiming
Autor:
Bruno Vincent Luukinen, Mika Rämet, Eric Dufour, Hanna Luukinen, Laura Kantanen, Vesa P. Hytönen, Sampsa Järvinen, Aleksandra Svorjova, Mataleena Parikka, Milka Hammaren, Leena-Maija Vanha-aho
Publikováno v:
Disease Models & Mechanisms, Vol 11, Iss 1 (2018)
Mycobacterium tuberculosis remains one of the most problematic infectious agents, owing to its highly developed mechanisms to evade host immune responses combined with the increasing emergence of antibiotic resistance. Host-directed therapies aiming